Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |